Laboratory Corporation of America Holdings
NYSE:LH

Watchlist Manager
Laboratory Corporation of America Holdings Logo
Laboratory Corporation of America Holdings
NYSE:LH
Watchlist
Price: 239.67 USD -0.21% Market Closed
Market Cap: 20B USD
Have any thoughts about
Laboratory Corporation of America Holdings?
Write Note

Laboratory Corporation of America Holdings
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Laboratory Corporation of America Holdings
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Laboratory Corporation of America Holdings
NYSE:LH
Total Current Liabilities
$3.4B
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
16%
DaVita Inc
NYSE:DVA
Total Current Liabilities
$2.9B
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
1%
Chemed Corp
NYSE:CHE
Total Current Liabilities
$264.8m
CAGR 3-Years
-3%
CAGR 5-Years
1%
CAGR 10-Years
3%
Quest Diagnostics Inc
NYSE:DGX
Total Current Liabilities
$2.1B
CAGR 3-Years
6%
CAGR 5-Years
1%
CAGR 10-Years
6%
CVS Health Corp
NYSE:CVS
Total Current Liabilities
$84.6B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
17%
Cigna Corp
NYSE:CI
Total Current Liabilities
$57.1B
CAGR 3-Years
23%
CAGR 5-Years
15%
CAGR 10-Years
22%
No Stocks Found

Laboratory Corporation of America Holdings
Glance View

Market Cap
20.1B USD
Industry
Health Care

Laboratory Corporation of America Holdings, commonly referred to as LabCorp, has established itself as a leader in the biomedical testing and diagnostics industry. Founded in 1971, the company operates with a mission to improve health and improve lives by providing critical laboratory services to healthcare providers, pharmaceutical companies, and patients. LabCorp offers a comprehensive range of tests, encompassing everything from routine blood work to complex genomic testing. This diverse portfolio positions LabCorp to benefit from the growing demand for diagnostic services, particularly as healthcare continues to evolve toward precision medicine and personalized care. For investors, LabCorp's strategic initiatives and strong financial performance paint a compelling picture. The company has successfully expanded through a series of acquisitions, enhancing its capabilities and market reach. With a focus on innovation, LabCorp has invested heavily in advanced technologies and digital solutions to streamline operations and enhance customer experience. As the healthcare landscape shifts toward value-based care, LabCorp is well-positioned to capture market share and drive revenue growth. With a history of consistent earnings and a commitment to shareholder value, LabCorp represents a potentially attractive investment for those looking to engage in the evolving healthcare sector.

LH Intrinsic Value
259.89 USD
Undervaluation 8%
Intrinsic Value
Price

See Also

What is Laboratory Corporation of America Holdings's Total Current Liabilities?
Total Current Liabilities
3.4B USD

Based on the financial report for Sep 30, 2024, Laboratory Corporation of America Holdings's Total Current Liabilities amounts to 3.4B USD.

What is Laboratory Corporation of America Holdings's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
16%

Over the last year, the Total Current Liabilities growth was 18%. The average annual Total Current Liabilities growth rates for Laboratory Corporation of America Holdings have been 6% over the past three years , 6% over the past five years , and 16% over the past ten years .

Back to Top